Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
. (2022) Theme 09 - Clinical Trials and Trial Design. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:sup1, pages 133-149.
Read now
Read now
James D. Berry, Richard Bedlack, Debra Mathews, Wendy Agnese & Stephen Apple. (2021) Engaging ALS patients and caregivers (the ALS research ambassadors) to help design the REFINE-ALS biomarker study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:1-2, pages 147-150.
Read now
Read now
Articles from other publishers (1)
Christina N. Fournier. (2022) Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design. Neurotherapeutics 19:4, pages 1180-1192.
Crossref
Crossref